Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 440日前

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

RTTNews | 534日前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 712日前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1086日前

TSX Pares Gains After Hitting Fresh Record High; Gildan Activewear Soars 11%

Despite coming off early highs, the Canadian market remains in positive territory on Wednesday afternoon, supported by gains in consumer discretionary, communications and real estate sectors. Stocks from financial section are also faring reasonably well.

RTTNews | 1時20分前

Swiss Market Ends On Firm Note

The Switzerland market closed on a firm note on Wednesday, despite struggling for support mid way through the day's trading session. Investors largely made their moves, reacting to the most recent earnings updates.

RTTNews | 1時44分前

European Stocks Close Mostly Higher

European stocks closed mostly higher on Wednesday on rising optimism about a rate cut by the Federal Reserve in September, and easing trade and geopolitical tensions. Gains were somewhat modest in several markets and traders chose to stay cautious at higher levels, choosing to wait for more economic data, and news from the tariff front.

RTTNews | 2時2分前

Bay Street Likely To Open On Positive Note

Canadian stocks may open higher on Wednesday, amid continued optimism about Fed interest rate cut, and easing geopolitical tensions ahead of talks between U.S. President Donald Trump and Russian President Vladimir Putin that is scheduled to take place on Friday.

RTTNews | 6時46分前

EURUSD	1.16993	GBPUSD	1.35667	AUDUSD	0.65419
USDJPY	147.455	USDCAD	1.37699	USDCHF	0.80561